Afeyan Noubar's Form 4 filing
Axcella Health Inc. (AXLA) · filed Mar 18, 2022
- Accession no.
- 0000899243-22-011535
- Filed
- Mar 18, 2022, 8:30 AM ET
- Trade date
- Mar 16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $12.1M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | 10% Owner |
| Flagship Ventures Fund IV, L.P.CIK 0001503559 | 10% Owner |
| Flagship Ventures Fund IV General Partner LLCCIK 0001508051 | 10% Owner |
| Flagship Ventures Fund IV-Rx, L.P.CIK 0001590973 | 10% Owner |
| Flagship Ventures Opportunities Fund I, L.P.CIK 0001677345 | 10% Owner |
| Flagship Ventures Opportunities Fund I General Partner LLCCIK 0001725004 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock | PPurchaseAcquired | +3,791,623 | $1.91 | +$7,241,999.93 | 8,600,403 | Indirect | |
| Mar 16, 2022 | Common Stock | PPurchaseAcquired | +947,905 | $1.91 | +$1,810,498.55 | 2,004,657 | Indirect | |
| Mar 16, 2022 | Common Stock | PPurchaseAcquired | +1,579,843 | $1.91 | +$3,017,500.13 | 4,465,866 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.